CURE Magazine - Nov. 30
According to Damon Reed, M.D., who leads the AYA program at Moffitt Cancer Center in Florida, this group has not seen the improvement in cancer survival rates observed in older and younger patients. “What’s really shocking is that if you’re a 30-year-old and you have a cancer that’s more common in 60-year-olds, you do worse than them,” Reed says.
Florida Business Observer – Nov. 30
Moffitt Cancer Center has appointed Karen Wartenberg vice president of the Moffitt Medical Group, Florida’s largest multidisciplinary medical group practice dedicated to cancer care.
WSVN – Nov. 29
Memorial Hospital West in Pembroke Pines celebrated their brand new Moffitt Cancer Center, Wednesday, where patients with blood-related cancers can receive life-saving treatments.
Med Device Online – Nov. 29
“The way Cvergenx has been able to develop as a company so far, with minimal investment, is to partner with the Moffitt Cancer Center and Research Institute.” Though this approach is not unique to Cvergenx, it is rare to achieve this level of ‘collaboration’ with a research organization.
PR Sync – Nov. 30
According to the research article published in Journal of the Moffitt Cancer Center, around 1 million breast cancers are diagnosed globally among them 1.7% of cancer cases are triple-negative cancers.
ASCO Post – Nov. 29
Although a majority of major cancer centers may test for minimal residual disease (MRD), a recent survey conducted by researchers at Moffitt Cancer Center, Tampa, Florida, suggests most oncologists remain uncertain about what to do with the results.
Miami Herald – Nov. 28
Tampa’s H. Lee Moffitt Cancer Center and Research Institute, the state’s only National Cancer Institute-designated program, provides physicians and other healthcare professionals to staff the program, which launched on July 1 at Memorial Hospital West.
Pharmacy Choice – Nov. 28
CAR T-Cell Therapy for Your Patients: What You Need to Know, will air live online Tuesday, December 5, 2107, from 1:30-2:30 PM EST, featuring Marco L. Davila, MD, PhD, Medical Oncologist with H. Lee Moffitt Cancer Center & Research Institute. Following the live broadcast, the program will be available on OMedLive through December 2018.
Digital Journal – Nov. 28
Ponce Health Sciences University (PHSU) of Ponce, Puerto Rico, in partnership with the H. Lee Moffitt Cancer Center (MCC) of Tampa, FL, has received a type U54 grant of $16,000,000 from the National Cancer Institute (NCI).
PR Newswire - Nov. 20
ITUS Corporation (NASDAQ: ITUS) today announced that it has entered into a Cooperative Research and Development Agreement (CRADA) with Moffitt Cancer Center, to advance toward human clinical testing, a Chimeric Antigen Receptor T-Cell (CAR-T) technology aimed initially at Ovarian Cancer, and eventually additional solid tumors.
Targeted Oncology – Nov. 17
Richard Kim, MD, associate professor of oncology, Moffitt Cancer Center, explained his treatment decisions based on 2 case scenarios during a Targeted Oncology live case-based peer perspectives dinner.
Please note we cannot guarantee the accuracy or availability of links. The stories belong to the respective publishers, and links may expire. Some news sites require you to register and select a password in order to retrieve articles, but most usually do not charge a fee to retrieve these news stories.